These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
610 related items for PubMed ID: 19793694
1. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients]. Biró K. Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694 [Abstract] [Full Text] [Related]
2. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission. Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I. Oncology; 2006 Sep; 70(3):177-84. PubMed ID: 16757924 [Abstract] [Full Text] [Related]
3. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)]. Biró K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I. Magy Onkol; 2006 Sep; 50(4):329-35. PubMed ID: 17216007 [Abstract] [Full Text] [Related]
4. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D. Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950 [Abstract] [Full Text] [Related]
5. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model. Dille MF, McMillan GP, Reavis KM, Jacobs P, Fausti SA, Konrad-Martin D. J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453 [Abstract] [Full Text] [Related]
8. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. Knight KR, Kraemer DF, Winter C, Neuwelt EA. J Clin Oncol; 2007 Apr 01; 25(10):1190-5. PubMed ID: 17401008 [Abstract] [Full Text] [Related]
11. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O. J Pediatr Hematol Oncol; 2004 Oct 01; 26(10):649-55. PubMed ID: 15454836 [Abstract] [Full Text] [Related]
12. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)]. Hoth S. Laryngorhinootologie; 1996 Dec 01; 75(12):709-18. PubMed ID: 9081275 [Abstract] [Full Text] [Related]
14. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected. Schmidt CM, Knief A, Lagosch AK, Deuster D, am Zehnhoff-Dinnesen A. Ear Hear; 2008 Dec 01; 29(6):830-7. PubMed ID: 18772725 [Abstract] [Full Text] [Related]
16. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia]. Lisowska G, Namysłowski G, Hajduk A, Polok A, Tomaszewska R, Misiołek M. Otolaryngol Pol; 2006 Dec 01; 60(3):415-20. PubMed ID: 16989457 [Abstract] [Full Text] [Related]
17. Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors. Oldenburg J, Kraggerud SM, Cvancarova M, Lothe RA, Fossa SD. J Clin Oncol; 2007 Feb 20; 25(6):708-14. PubMed ID: 17228018 [Abstract] [Full Text] [Related]
18. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children. Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G. Int J Pediatr Otorhinolaryngol; 2001 May 31; 59(1):47-57. PubMed ID: 11376818 [Abstract] [Full Text] [Related]
19. [Effects of Cisplatin on Auditory Function in Children with cancer. Otoacoustic Emission Evaluation]. Toral-Martiñón R, Poblano A, Collado-Corona MA, González R. Gac Med Mex; 2003 May 31; 139(6):529-34. PubMed ID: 14723047 [Abstract] [Full Text] [Related]